Medicine & Life Sciences
Ethiopia
100%
Visceral Leishmaniasis
88%
Guinea
49%
HIV
46%
Disease Outbreaks
36%
Ebola Hemorrhagic Fever
35%
Cambodia
33%
Cutaneous Leishmaniasis
27%
Sierra Leone
20%
Coinfection
18%
Belgium
17%
Zika Virus
16%
Leishmaniasis
16%
Therapeutics
15%
Hepacivirus
15%
Routine Diagnostic Tests
15%
Tuberculosis
15%
HIV Infections
14%
Malaria
13%
Myanmar
13%
Chikungunya virus
13%
Retrospective Studies
13%
Democratic Republic of the Congo
13%
Polymerase Chain Reaction
13%
Hepatitis C
12%
Cohort Studies
11%
miltefosine
11%
Leishmania
11%
Recurrence
11%
Eastern Africa
11%
Schistosomiasis
11%
Clinical Trials
11%
Microscopy
11%
Genotype
10%
Pentamidine
10%
Zika Virus Infection
10%
Cross-Sectional Studies
10%
Fever
9%
Elephantiasis
9%
Africa South of the Sahara
9%
liposomal amphotericin B
8%
Antibodies
8%
Mortality
8%
Paromomycin
8%
Antimony Sodium Gluconate
8%
Neglected Diseases
8%
Referral and Consultation
8%
Antigens
7%
Leprosy
7%
Child
7%
Health Facilities
7%
Aspirations (Psychology)
7%
Vaccines
7%
Treatment Failure
7%
Virus Diseases
7%
Survivors
6%
Aruba
6%
Infection
6%
Skin
6%
Enzyme-Linked Immunosorbent Assay
6%
Confidence Intervals
6%
CD4 Lymphocyte Count
6%
Monkeypox virus
6%
Epidemics
6%
Sensitivity and Specificity
6%
Safety
6%
picaridin
6%
Monkeypox
6%
Schistosoma
6%
Pandemics
5%
Delivery of Health Care
5%
Tropical Medicine
5%
Evaluation Studies
5%
2-(pyrrolidin-2-yl)-5-(2-(4-(5-(pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole
5%
MK-5172
5%
Guidelines
5%
Mass Drug Administration
5%
Insect Repellents
5%
Sudan
5%
Emergencies
5%
Swaziland
5%
Scabies
5%
Serum
5%